March edition of circulation discusses cadherin 2 (CHD 2) gene which is involved in adherence between cardiac cells is the culprit gene in sudden cardiac death in healthy young adults. Is it opening new targets to prevent it or screening scope? At present it's just a theoretical description for the cause arrhythmogenic right ventricular cardiomyopathy, but it's not available for screening of young people but bring in justification of SCD in youngsters, which some of us might have encountered in our practice.
Does it bring hope for young athletes to screen for the gene to predict their risk? Have you ever faced such a tragedy, which can invite many legal problems, for a poor practitioner who has to be at the gun point these days, how you got out of it? Kindly share good or bad experiences.
